יחס חוב לטווח ארוך להון Arcus Corp (RCUS)
The market trend for Arcus Biosciences, Inc. (RCUS) analyzed on the GURU.Markets price chart, where the individual long-term debt indicator stands at 0.21, operates within the field of cancer immunotherapy. The company's authority is bolstered by collaborations with major pharmaceutical giants and recognition from the scientific community. The business is insulated from economic cycles, with its viability determined by liquidity levels. Growth potential is based on patents that enable the profitable global sale of its developments.
פילוחים אנליטיים של חברת Arcus Biosciences, Inc.
Aggressively retaining the R&D core and attracting clinicians requires stable funding, making the control of long-term liabilities critically important for Arcus Biosciences, Inc. (RCUS). The ratio of loans with a maturity of more than one year to equity measures financial leverage and solvency, allowing an investor to assess the risk of over-indebtedness through the structure of long-term debt relative to capital.